• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用冠状动脉钙化积分评估中重度心血管危险因素患者血清骨保护素水平与冠状动脉钙化的相关性

Correlation between Osteoprotegerin Serum Level and Coronary Calcification Using Coronary Artery Calcium Score in Patient with Moderate-Severe Cardiovascular Risk Factor.

作者信息

Nugroho J, Widorini Widorini

机构信息

Department of Cardiology and Vascular Medicine, Soetomo General Hospital, Airlangga University, Surabaya, East Java, Indonesia.

出版信息

Int J Angiol. 2017 Dec;26(4):234-237. doi: 10.1055/s-0037-1607050. Epub 2017 Oct 4.

DOI:10.1055/s-0037-1607050
PMID:29142489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5685791/
Abstract

Coronary artery calcification is a part of atherosclerosis process associated with coronary heart disease. Recently, coronary artery calcification assessment using computed tomography (CT) is still the best noninvasive imaging with high sensitivity and specificity. Osteoprotegerin (OPG) is one of vascular calcification marker that through its role to bind receptor activator of nuclear factor-κβ ligand and inhibit osteoclastogenesis is suspected of playing a role for coronary calcification in atherosclerosis process. The objective of this study was to prove a positive correlation between OPG serum level and coronary calcification using coronary artery calcium (CAC) score in patient with moderate-severe cardiovascular (CV) risk factor. This is a cross-sectional study with purposive sampling technique. Thirty-three subjects participate in this research and each subject underwent a multislice computed tomography (MSCT) examination to assess coronary calcification and their blood samples were collected for OPG measurement. This study is analyzed with Spearman's correlation test. The mean of OPG serum level in this study was 5.89 ± 2.1 pmol/L for moderate-risk Framingham risk score (FRS) and the mean of OPG serum level for high-risk FRS was 7.27 ± 3.4. There was a positive, moderate, and significant correlation between OPG serum level and coronary calcification using CAC score in patient with moderate-severe CV risk factor (  = 0.694;  < 0.001).

摘要

冠状动脉钙化是与冠心病相关的动脉粥样硬化过程的一部分。最近,使用计算机断层扫描(CT)进行冠状动脉钙化评估仍然是具有高灵敏度和特异性的最佳非侵入性成像方法。骨保护素(OPG)是血管钙化标志物之一,通过其结合核因子κB受体激活剂配体并抑制破骨细胞生成的作用,被怀疑在动脉粥样硬化过程中对冠状动脉钙化起作用。本研究的目的是在患有中度至重度心血管(CV)危险因素的患者中,使用冠状动脉钙化(CAC)评分来证明OPG血清水平与冠状动脉钙化之间存在正相关。这是一项采用目的抽样技术的横断面研究。33名受试者参与了本研究,每位受试者均接受了多层计算机断层扫描(MSCT)检查以评估冠状动脉钙化,并采集他们的血样进行OPG测量。本研究采用Spearman相关性检验进行分析。对于中度风险的弗雷明汉风险评分(FRS),本研究中OPG血清水平的平均值为5.89±2.1 pmol/L,对于高风险FRS,OPG血清水平的平均值为7.27±3.4。在患有中度至重度CV危险因素的患者中,使用CAC评分时,OPG血清水平与冠状动脉钙化之间存在正相关、中度相关且具有显著相关性(r = 0.694;P < 0.001)。

相似文献

1
Correlation between Osteoprotegerin Serum Level and Coronary Calcification Using Coronary Artery Calcium Score in Patient with Moderate-Severe Cardiovascular Risk Factor.使用冠状动脉钙化积分评估中重度心血管危险因素患者血清骨保护素水平与冠状动脉钙化的相关性
Int J Angiol. 2017 Dec;26(4):234-237. doi: 10.1055/s-0037-1607050. Epub 2017 Oct 4.
2
Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.骨保护素对2型糖尿病患者冠状动脉钙化的预测价值及其与多排螺旋计算机断层扫描检测到的钙化程度的相关性
Endocr Metab Immune Disord Drug Targets. 2019;19(6):845-851. doi: 10.2174/1871530319666190211122858.
3
Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.严重动脉钙化的血液透析患者血浆中骨保护素水平升高。
Ther Apher Dial. 2018 Oct;22(5):519-529. doi: 10.1111/1744-9987.12681. Epub 2018 Jul 4.
4
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.单纯2型糖尿病患者血浆骨保护素水平与冠状动脉钙化之间的关系。
J Am Coll Cardiol. 2006 May 2;47(9):1850-7. doi: 10.1016/j.jacc.2005.12.054. Epub 2006 Apr 19.
5
Evaluation of the role of severe hyperparathyroidism on coronary artery calcification in dialysis patients.评估严重甲状旁腺功能亢进在透析患者冠状动脉钙化中的作用。
Clin Nephrol. 2007 Feb;67(2):89-95. doi: 10.5414/cnp67089.
6
Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification.严重冠状动脉钙化患者血浆中白细胞介素-37水平升高。
J Geriatr Cardiol. 2017 May;14(5):285-291. doi: 10.11909/j.issn.1671-5411.2017.05.013.
7
Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies.骨保护素与糖尿病患者冠状动脉钙化的相关性:观察性研究的系统评价。
BMC Cardiovasc Disord. 2023 Feb 21;23(1):96. doi: 10.1186/s12872-023-03123-z.
8
The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.韩国人中骨保护素基因启动子区域的四个单核苷酸多态性与主动脉钙化或冠状动脉疾病之间的关系。
Clin Endocrinol (Oxf). 2006 Jun;64(6):689-97. doi: 10.1111/j.1365-2265.2006.02530.x.
9
Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects.骨保护素,而非骨桥蛋白,作为预测正常血压受试者血管钙化的潜在标志物。
Hypertens Res. 2012 May;35(5):531-8. doi: 10.1038/hr.2011.231. Epub 2012 Jan 26.
10
Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease.血清骨保护素与代谢状态、严重程度及后续冠心病估计风险的关系。
Arch Iran Med. 2014 Sep;17(9):596-601.

引用本文的文献

1
Omega-3 fatty acid and menaquinone-7 combination are helpful for aortic calcification prevention, reducing osteoclast area of bone and Fox0 expression of muscle in uremic rats.ω-3 脂肪酸与甲萘醌-7 联合应用有助于预防主动脉钙化,减少尿毒症大鼠骨破骨细胞面积和肌肉 Fox0 表达。
Ren Fail. 2022 Dec;44(1):1873-1885. doi: 10.1080/0886022X.2022.2142140.
2
Serum biomarkers for arterial calcification in humans: A systematic review.人类动脉钙化的血清生物标志物:一项系统综述。
Bone Rep. 2022 Jun 18;17:101599. doi: 10.1016/j.bonr.2022.101599. eCollection 2022 Dec.
3
Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis.地诺单抗可在长期血液透析过程中恢复主动脉弓钙化。
Kidney Int Rep. 2020 Dec 16;6(3):605-612. doi: 10.1016/j.ekir.2020.12.002. eCollection 2021 Mar.

本文引用的文献

1
Clinician's guide to the updated ABCs of cardiovascular disease prevention.心血管疾病预防最新ABCs临床指南
J Am Heart Assoc. 2014 Sep 22;3(5):e001098. doi: 10.1161/JAHA.114.001098.
2
Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification.循环骨保护素在代谢综合征中升高,并与亚临床动脉粥样硬化和冠状动脉钙化相关。
Clin Biochem. 2014 Dec;47(18):272-8. doi: 10.1016/j.clinbiochem.2014.09.004. Epub 2014 Sep 16.
3
Coronary artery calcification: pathogenesis and prognostic implications.冠状动脉钙化:发病机制及预后意义。
J Am Coll Cardiol. 2014 May 6;63(17):1703-14. doi: 10.1016/j.jacc.2014.01.017. Epub 2014 Feb 12.
4
The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology.心血管疾病的全球环境:流行情况、诊断、治疗和政策问题:美国心脏病学会的报告。
J Am Coll Cardiol. 2012 Dec 25;60(25 Suppl):S1-49. doi: 10.1016/j.jacc.2012.11.002.
5
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》(2012年版)。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第五版(由九个学会的代表及特邀专家组成)。
Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.
6
Cardiac risk stratification: role of the coronary calcium score.心脏风险分层:冠状动脉钙化积分的作用。
Vasc Health Risk Manag. 2010 Aug 9;6:603-11. doi: 10.2147/vhrm.s8753.
7
Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity.骨保护素作为冠心病及心血管病病死率和发病率的预测指标。
J Am Coll Cardiol. 2010 May 11;55(19):2049-61. doi: 10.1016/j.jacc.2010.03.013.
8
Expert review on coronary calcium.冠状动脉钙化专家综述
Vasc Health Risk Manag. 2008;4(2):315-24. doi: 10.2147/vhrm.s1160.
9
Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.骨保护素上调内皮细胞黏附分子对与血管生成素-2诱导相关的肿瘤坏死因子-α的反应。
Cardiovasc Res. 2007 Dec 1;76(3):494-505. doi: 10.1016/j.cardiores.2007.07.017. Epub 2007 Aug 2.
10
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography).美国心脏病学会基金会/美国心脏协会2007年关于计算机断层扫描冠状动脉钙化评分在全球心血管风险评估及胸痛患者评估中的临床专家共识文件:美国心脏病学会基金会临床专家共识工作组报告(美国心脏病学会基金会/美国心脏协会写作委员会更新2000年电子束计算机断层扫描专家共识文件)
Circulation. 2007 Jan 23;115(3):402-26. doi: 10.1161/CIRCULATIONAHA..107.181425. Epub 2007 Jan 12.